BIM, another pro-apoptotic protein, was found to be crucial for potentiation of VEN efficacy by dexamethasone and imatinib in Ph-positive BCP-ALL models [19]. The gene discussed is BCL2L11; the disease is acute lymphoblastic leukemia.